Nevirapine + Lamivudine + StavudineThird Party Manufacturing in India
Looking to get Nevirapine + Lamivudine + Stavudine manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.
Mechanism of Action
This combination works by providing a triple-action blockade of the HIV-1 reverse transcriptase enzyme.
Nevirapine binds to an allosteric site to non-competitively inhibit the enzyme, while Lamivudine and Stavudine are nucleoside analogues that competitively inhibit the enzyme and cause premature DNA chain termination. This synergistic mechanism robustly halts viral replication and reduces the risk of viral resistance.
Unlike single-agent therapy, this formulation offers a complete and highly effective solution for long-term suppression of the virus in affected patients.
Therapeutic Uses & Indications
Therapeutic Uses
This fixed-dose combination is prescribed for the treatment of:
- HIV-1 Infection: Used as a complete antiretroviral regimen for the management of HIV/AIDS in adult and pediatric patients.
Why Manufacturers Choose This Combination
Fixed-dose combinations significantly improve patient compliance by reducing pill burden, a critical factor in successful antiretroviral therapy. The proven synergy of Nevirapine, Lamivudine, and Stavudine offers a cost-effective and potent treatment option.
This makes it one of the most sought-after combinations for third party manufacturing in India, with consistent demand for export to emerging markets and global health initiatives.
Dosage Forms We Manufacture
Frequently Asked Questions
What is the minimum order quantity for Nevirapine + Lamivudine + Stavudine?
What dosage forms of Nevirapine + Lamivudine + Stavudine can you manufacture?
Are your manufacturing facilities WHO-GMP certified?
Can you manufacture Nevirapine + Lamivudine + Stavudine for export?
What grade standards do you follow for Nevirapine + Lamivudine + Stavudine?
Get Nevirapine + Lamivudine + Stavudine made under your brand
- WHO-GMP certified facilities
- Quote within 24 hours
- MOQ from 10,000 tablets per batch
+91 9689237122 · replies within hours
Our Manufacturing Capabilities
- WHO-GMP Certified Partner Plants
- 25+ years of pharma industry experience
- PCD Franchise with monopoly rights
- Export support across 25+ countries
- Small batch to commercial scale
- Custom formulation development
Packaging Options
HDPE bottle, Blister pack (Alu-Alu). Packaging customized to client brand guidelines.
Start Manufacturing Nevirapine + Lamivudine + Stavudine Today
Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Nevirapine + Lamivudine + Stavudine across all dosage forms. PCD franchise and export orders welcome.